|
|
|
|
An Aspiring Blockbuster
Novartis (NYSE: NVS) may ASPIRE for great things from blood pressure medication Tekturna, but its latest clinical trial won't help.Perhaps we should have suspected the worst when the company had to stretch to name the trial ASPIRE (Aliskiren Study in Post-MI...
|
|
|
Pfizer could be going the generic route
Pfizer's Established Products division already has sales of $2.7 billion through marketing its own products such as Norvasc and Zoloft Financial Times If you can't beat 'em, join 'em.Once a dirty word, generics is entering the vocabulary of some of the...
|
|
|
Pfizer's Hsinchu factory is biggest in Taiwan
HSINCHU, Taiwan -- Pfizer, the world's largest research-based pharmaceutical company, acquired Wyeth last year.The company's Hsinchu factory is the only pharmaceutical factory in Taiwan owned by a multinational company. 'For years, the Pfizer Hsinchu...
|
|
|
Antihypertensive Combo May Save Kidney Function
By Nancy Walsh, Contributing Writer, MedPage TodayPublished: February 18, 2010Reviewed by Emeritus Professor University of Pennsylvania School of Medicine.Action Points Explain to interested patients that a study suggested that a combination antihypertensive...
|
|
|
Top 10 drugs from new Merck, new Pfizer
UPDATED: Added direct link to Merck release The Associated Press has put out a helpful list of Merck's top-selling drugs for the fourth quarter, now that it has merged with Schering-Plough.So we thought we'd take a look at the other megamerger--Pfizer and...
|
|
|
Top 10 drugs from new Merck, new Pfizer
The Associated Press has put out a helpful list of Merck's top-selling drugs for the fourth quarter, now that it has merged with Schering-Plough.So we thought we'd take a look at the other megamerger--Pfizer and Wyeth--and Merck's list, too. The names on...
|
|
|
Pfizer posts big jump in 4Q sales, profit
TRENTON, N.J.Drugmaker Pfizer Inc., well into integrating its new Wyeth unit, posted a 34 percent jump in revenue Wednesday, but $3.2 billion in acquisition and restructuring charges and higher costs across the board weighed down profit. The maker of...
|
